129 related articles for article (PubMed ID: 37017658)
1. Potentiation of Antitumor Activity by Antibody Drugs and Mushroom-Derived β-Glucans in Natural Killer Cell-Mediated Tumoricidal Activities against Non-Hodgkin's B-Cell Lymphoma.
Adachi Y; Momose F; Momose H; Tada R; Ohno N
Int J Med Mushrooms; 2023; 25(3):1-19. PubMed ID: 37017658
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-macrophage colony-stimulating factor (GM-CSF) regulates cytokine induction by 1,3-beta-D-glucan SCG in DBA/2 mice in vitro.
Harada T; Miura NN; Adachi Y; Nakajima M; Yadomae T; Ohno N
J Interferon Cytokine Res; 2004 Aug; 24(8):478-89. PubMed ID: 15320961
[TBL] [Abstract][Full Text] [Related]
3. Concurrent administration of granulocyte colony-stimulating factor or granulocyte-monocyte colony-stimulating factor enhances the biological activity of rituximab in a severe combined immunodeficiency mouse lymphoma model.
Hernandez-Ilizaliturri FJ; Jupudy V; Reising S; Repasky EA; Czuczman MS
Leuk Lymphoma; 2005 Dec; 46(12):1775-84. PubMed ID: 16263581
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of soluble β-glucan preparation from the cauliflower mushroom, Sparassis crispa (Higher Basidiomycetes) modulated cytokine production in mice.
Hida TH; Kawaminami H; Ishibashi K; Miura NN; Adachi Y; Ohno N
Int J Med Mushrooms; 2013; 15(6):525-38. PubMed ID: 24266377
[TBL] [Abstract][Full Text] [Related]
5. Effect of Sasa veitchii extract on immunostimulating activity of β-glucan (SCG) from culinary-medicinal mushroom Sparassis crispa Wulf.:Fr. (higher Basidiomycetes).
Yoshida M; Hida TH; Takeshita K; Tsuboi M; Kanamori M; Akachi N; Miura NN; Adachi Y; Ohno N
Int J Med Mushrooms; 2012; 14(6):537-47. PubMed ID: 23510247
[TBL] [Abstract][Full Text] [Related]
6. Cell to cell contact through ICAM-1-LFA-1 and TNF-alpha synergistically contributes to GM-CSF and subsequent cytokine synthesis in DBA/2 mice induced by 1,3-beta-D-Glucan SCG.
Harada T; Kawaminami H; Miura NN; Adachi Y; Nakajima M; Yadomae T; Ohno N
J Interferon Cytokine Res; 2006 Apr; 26(4):235-47. PubMed ID: 16704300
[TBL] [Abstract][Full Text] [Related]
7. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
Hernandez-Ilizaliturri FJ; Jupudy V; Ostberg J; Oflazoglu E; Huberman A; Repasky E; Czuczman MS
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5866-73. PubMed ID: 14676108
[TBL] [Abstract][Full Text] [Related]
8. Contribution of dectin-1 and granulocyte macrophage-colony stimulating factor (GM-CSF) to immunomodulating actions of beta-glucan.
Harada T; Ohno N
Int Immunopharmacol; 2008 Apr; 8(4):556-66. PubMed ID: 18328447
[TBL] [Abstract][Full Text] [Related]
9. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
10. Enhanced cytokine synthesis of leukocytes by a beta-glucan preparation, SCG, extracted from a medicinal mushroom, Sparassis crispa.
Nameda S; Harada T; Miura NN; Adachi Y; Yadomae T; Nakajima M; Ohno N
Immunopharmacol Immunotoxicol; 2003 Aug; 25(3):321-35. PubMed ID: 19180796
[TBL] [Abstract][Full Text] [Related]
11. [Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells].
Shi YX; Zhang XS; Xia JC; Li YQ; Xu RH; Han WJ; Zhang JH; Guan ZZ; Jiang WQ
Ai Zheng; 2007 Aug; 26(8):837-42. PubMed ID: 17697543
[TBL] [Abstract][Full Text] [Related]
12. Effect of GM-CSF on cytokine induction by soluble beta-glucan SCG in vitro in beta-glucan-treated mice.
Hida TH; Kawaminami H; Ishibashi K; Miura NN; Adachi Y; Yadomae T; Ohno N
Microbiol Immunol; 2009 Jul; 53(7):391-402. PubMed ID: 19563398
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of enhanced hematopoietic response by soluble beta-glucan SCG in cyclophosphamide-treated mice.
Harada T; Kawaminami H; Miura NN; Adachi Y; Nakajima M; Yadomae T; Ohno N
Microbiol Immunol; 2006; 50(9):687-700. PubMed ID: 16985290
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal Lym-1 antibody-dependent lysis of B-lymphoblastoid tumor targets by human complement and cytokinine-exposed mononuclear and neutrophilic polymorphonuclear leukocytes.
Ottonello L; Morone P; Dapino P; Dallegri F
Blood; 1996 Jun; 87(12):5171-8. PubMed ID: 8652830
[TBL] [Abstract][Full Text] [Related]
15. The polysaccharide, PGG-glucan, enhances human myelopoiesis by direct action independent of and additive to early-acting cytokines.
Turnbull JL; Patchen ML; Scadden DT
Acta Haematol; 1999; 102(2):66-71. PubMed ID: 10529508
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte macrophage colony-stimulating factor is required for cytokine induction by a highly 6-branched 1,3-β-D-glucan from Aureobasidium pullulans in mouse-derived splenocytes.
Tada R; Yoshikawa M; Kuge T; Tanioka A; Ishibashi K; Adachi Y; Tsubaki K; Ohno N
Immunopharmacol Immunotoxicol; 2011 Jun; 33(2):302-8. PubMed ID: 20672970
[TBL] [Abstract][Full Text] [Related]
17. Soluble β-glucan from Grifola frondosa induces proliferation and Dectin-1/Syk signaling in resident macrophages via the GM-CSF autocrine pathway.
Masuda Y; Togo T; Mizuno S; Konishi M; Nanba H
J Leukoc Biol; 2012 Apr; 91(4):547-56. PubMed ID: 22028332
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
[TBL] [Abstract][Full Text] [Related]
19. Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.
Liu Z; Lee FT; Hanai N; Smyth FE; Burgess AW; Old LJ; Scott AM
Cancer Immun; 2002 Oct; 2():13. PubMed ID: 12747758
[TBL] [Abstract][Full Text] [Related]
20. Colony-stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumour cells.
Baldwin GC; Chung GY; Kaslander C; Esmail T; Reisfeld RA; Golde DW
Br J Haematol; 1993 Apr; 83(4):545-53. PubMed ID: 7686031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
